Brooks Laboratories Ltd (BROOKS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 539063, "name": "Brooks Lab.", "stock_name": "Brooks Lab.", "full_name": "Brooks Laboratories Ltd", "name_url": "stocks-analysis/brooks-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "61.39", "chg": -0.84, "chgp": "-1.35%", "dir": -1, "prev_price": "62.23", "mcapval": "183.00 Cr", "mcap": "Micro Cap", "scripcode": 533543, "symbol": "BROOKS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE650L01011", "curr_date": "Sep 18, 03:30 PM", "curr_time": "08:47 AM", "last_traded_at": "Sep 18, 03:30 PM IST", "bse_nse_vol": "54.62 k", "exc_status": "Active", "traded_date": "Sep 18, 2026", "traded_date_str": "2026 09 18", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brooks-lab-539063-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Brooks Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4192368", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BrooksLaborator_mojoScore_4192368.png", "date": "2026-09-14 10:10:46", "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 September 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Brooks Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4179344", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BrooksLaborator_mojoScore_4179344.png", "date": "2026-09-02 10:11:11", "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 September 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-momentum-4173579", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_stocks_hitting_upper_circuit_4173579.png", "date": "2026-08-28 12:00:07", "description": "At Rs 69.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.99% on 28 Aug 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-4171660", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_stocks_hitting_upper_circuit_4171660.png", "date": "2026-08-27 11:00:07", "description": "At Rs 65.99, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 5.0% on 27 Aug 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Brooks Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4164802", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_mojoScore_4164802.png", "date": "2026-08-22 10:10:39", "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Brooks Laboratories Gains 3.29%: 5 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-gains-329-5-key-factors-driving-the-weeks-volatility-4155915", "imagepath": "", "date": "2026-08-15 17:02:19", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>10 Aug:</strong> Mojo Grade upgraded from Strong Sell to Sell</p>\n <p><strong>12 Aug:</strong> Stock hits upper circuit with 4.94% gain</p>\n <p><strong>13 Aug:</strong> Another upper circuit hit, gaining 4.99%</p>\n <p><strong>14 Aug:</strong> Reports negative quarterly financial trend</p>\n <p><strong>14 Aug:</strong> Stock plunges to lower circuit, down 5.0%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.60.85</div></div>\n <div class=\"stat-item\"><div class=\"st..." }, { "title": "Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 5.0% in a Single Session", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-4153826", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_stocks_hitting_lower_circuit_4153826.png", "date": "2026-08-14 14:00:08", "description": "At Rs 62.32, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5.0% on 14 Aug 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand." }, { "title": "Brooks Laboratories Ltd Reports Negative Quarterly Financial Trend Amid Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-reports-negative-quarterly-financial-trend-amid-margin-pressures-4153724", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_fintrenddot_4153724.png", "date": "2026-08-14 12:00:16", "description": "Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to negative, with key profitability metrics plunging and the stock price reflecting investor concerns amid broader market pressures." }, { "title": "Are Brooks Laboratories Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-brooks-laboratories-ltd-latest-results-good-or-bad-4152309", "imagepath": "", "date": "2026-08-13 19:44:30", "description": "Brooks Laboratories Ltd's latest financial results for the quarter ended March 2026 reveal significant operational challenges. The company reported consolidated net profit of ₹1.52 crores, which represents a substantial decline of 72.36% quarter-on-quarter and a dramatic 204.11% drop year-on-year. This sharp decrease in profitability raises concerns about the sustainability of its business model, particularly in the context of increasing competitive pressures within the pharmaceutical contract manufacturing sector.\n\nOn the revenue front, Brooks Laboratories experienced a quarter-on-quarter growth in net sales of 21.97%, reaching ₹20.21 crores. However, this growth is overshadowed by a year-on-year decline of 13.34%, indicating potential issues with demand or pricing power. The operating margin for the quarter fell to 3.36%, marking the lowest level in eight quarters, which suggests significant margin compre..." } ], "total": 353, "sid": "539063", "stock_news_url": "https://www.marketsmojo.com/news/brooks-laboratories-539063" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer", "datetime": "16-Sep-2026", "details": "Resignation of Ms. Krutika Rane as Company Secretary and Compliance Officer of the Company with effect from 9th October 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "16-Sep-2026", "details": "Newspaper Publication regarding re-lodgement of transfer deed.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "04-Sep-2026", "details": "Scrutinizer Report alongwith voting results for the AGM held on September 3 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Brooks Laboratories Ltd has announced <strong>1:16</strong> rights issue, ex-date: 28 Jul 23", "dt": "2023-07-28", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

10 Aug: Mojo Grade upgraded from Strong Sell to Sell

12 Aug: Stock hits upper circuit with 4.94% gain

13 Aug: Another upper circuit hit, gaining 4.99%

14 Aug: Reports negative quarterly financial trend

14 Aug: Stock plunges to lower circuit, down 5.0%

Week Open

Rs.60.85

Read full news article

Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 5.0% in a Single Session

2026-08-14 14:00:08

At Rs 62.32, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5.0% on 14 Aug 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

Read full news article

Brooks Laboratories Ltd Reports Negative Quarterly Financial Trend Amid Margin Pressures

2026-08-14 12:00:16

Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to negative, with key profitability metrics plunging and the stock price reflecting investor concerns amid broader market pressures.

Read full news article

Are Brooks Laboratories Ltd latest results good or bad?

2026-08-13 19:44:30

Brooks Laboratories Ltd's latest financial results for the quarter ended March 2026 reveal significant operational challenges. The company reported consolidated net profit of ₹1.52 crores, which represents a substantial decline of 72.36% quarter-on-quarter and a dramatic 204.11% drop year-on-year. This sharp decrease in profitability raises concerns about the sustainability of its business model, particularly in the context of increasing competitive pressures within the pharmaceutical contract manufacturing sector. On the revenue front, Brooks Laboratories experienced a quarter-on-quarter growth in net sales of 21.97%, reaching ₹20.21 crores. However, this growth is overshadowed by a year-on-year decline of 13.34%, indicating potential issues with demand or pricing power. The operating margin for the quarter fell to 3.36%, marking the lowest level in eight quarters, which suggests significant margin compre...

Read full news article